Impact of impaired fasting glucose and other metabolic factors on cognitive function in elderly people

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 3, 2007, Pages 203-208

  Di Bonito, P ^a   Di Fraia, L ^a   Di Gennaro, L ^a   Vitale, A ^a   Lapenta, M ^a   Scala, A ^a   Iardino, M R ^b   Cusati, B ^b   Attino, L ^c   Capaldo, B ^c  

^a Department of Internal Medicine   (Italy)

^b S Maria delle Grazie Hospital   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cognitive function; Dementia; Diabetes; Homocysteine; Impaired fasting glucose; Insulin resistance

Indexed keywords

AGED; ARTICLE; BLOOD; COGNITION; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; INSULIN RESISTANCE; MALE; PSYCHOLOGICAL ASPECT;

AGED; BLOOD GLUCOSE; COGNITION; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; INSULIN RESISTANCE; MALE;

EID: 33947096010     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.07.011     Document Type: Article

References (35)

1. Ott A., Breteler M.B., van Harskamp F., Claus J.J., van der Cammen T.J.M., Grobbee D.E., et al. The Rotterdam Study prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam Study. BMJ 310 (1995) 970-973
2. The DECODE Study Group. Age and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26 (2003) 61-69
3. Gregg E.W., Yaffe K., Cauley J.A., Rolka D.B., Blackwell T.L., Venkatt Narayan K.M., et al. Arch Intern Med 160 (2000) 174-180
4. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., and Bretler M.M.B. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 39 (1996) 1392-1397
5. Kanaya A.M., Barrett-Connor E., Gildengorin G., and Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo Study cohort. Arch Intern Med 28 (2004) 1327-1333
6. Grodstein F., Chen J., Wilson R.S., and Manson J.E. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24 (2001) 1060-1065
7. Bruce D.G., Casey G.P., Grange V., Clarnette R.C., Almeida P.O., Foster I.K., et al. Cognitive impairment, physical disability and depressive symptoms in older patients: the Freemantle cognition in diabetes study. Diabetes Res Clin Pract 53 (2001) 165-172
8. Scott R.D., Kritz-Silverstein D., Barret-Connor E., and Wiederholt W.C. The association of non-insulin-dependent diabetes mellitus and cognitive function in an older cohort. J Am Geriatr Soc 46 (1998) 1217-1222
9. Vanhanen M., Kuusisto J., Koivisto K., Mykkanen L., Helkala E.L., Hanninen T., et al. Type-2 diabetes and cognitive function in a non-demented population. Acta Neurol Scand 100 (1999) 97-101
10. Fontbonne A., Berr C., Ducimetriere P., and Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavourably affected in elderly diabetic subjects. Diabetes Care 24 (2001) 366-370
11. Logroscino G., Kang J.H., and Grodstein F. Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ 328 7439 (2004) 548
12. Kalmijn S., Feskens E.J.M., Launer L.J., Stijnen T., and Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 38 (1995) 1096-1102
13. Stolk R.P., Breteler M.M.B., Ott A., Pols H.A., Lamberts S.W.J., Grobbee D.E., et al. Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care 20 (1997) 792-795
14. Vanhanen M., Koivisto K., Kuusisto J., Mykkanen L., Helkala E.L., Hanninen T., et al. Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 21 (1998) 398-402
15. Lindeman R.D., Romero L.J., LaRue A., Yau C.L., Schade D.S., Koehler K.M., et al. A bi-ethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes Care 24 (2001) 1567-1572
16. Yaffe K., Blackwell T., Kanaya A.M., Davidowitz N., Barrett-Connor E., and Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63 (2004) 658-663
17. Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., Jolles J., Clarke R., et al. Homocysteine and cognitive function in the elderly. The Rotterdam Scan Study. Neurology 59 (2002) 1375-1380
18. Miller J.W., Green R., Ramos M.I., Allen L.H., Mungas D.M., Jagust W.J., et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on aging. Am J Clin Nutr 78 (2003) 441-447
19. Ravaglia G., Forti P., Maioli F., Muscari A., Sacchetti L., Arnone G., et al. Homocysteine and cognitive function in healthy community dwellers in Italy. Am J Clin Nutr 77 (2003) 668-673
20. Garcia A., and Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ 171 (2004) 897-904
21. Meigs J.B., Jacques P.F., Singer D.E., Nathan D.M., Rifal N., D'Agostino R.B., et al. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 24 (2001) 1403-1410
22. The Expert Committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
23. Magni E., Binetti G., Bianchetti A., Rozzini R., and Trabucchi M. Mini-mental state examination: a normative study in an Italian elderly population. Eur J Neurol 3 (1996) 1-5
24. Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., et al. Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc Natl Acad Sci U S A 24 (1994) 4766-4770
25. Meneilly G.S., Cheung E., Tessier D., Yakura C., and Tuokko H. The effect of improved glycaemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 48 (1993) M117-M121
26. Borch-Johnsen K., Colagiuri S., Balkau B., Glumer C., Carstensen B., Ramachandran A., et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47 (2004) 1396-2002
27. Tai E.S., Yen Goh S., Lee J.J.M., Wong M.S., Heng D., Hughes K., et al. Lowering the criterion for impaired fasting glucose. Diabetes Care 27 (2004) 1728-1734
28. Abbatecola A.M., Paolisso G., Lamponi M., Bandinelli S., Lauretani F., Launer L., et al. Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc 52 (2004) 1713-1718
29. Watson G.S., Peskind E.R., Asthana S., Purganan K., Wait C., Chapman D., et al. Insulin increases CSF Aβ42 levels in normal older adults. Neurology 60 (2003) 1899-1903
30. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., et al. Insulin-degrading enzyme regulates the levels of insulin, myloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100 (2003) 4162-4167
31. Morris M.S., Jacques P.F., Rosenberg I.H., and Selhub J. Hyperhomocysteinaemia associated with poor recall in the National Health and Nutrition Examination Survey. Am J Clin Nutr 73 (2001) 927-933
32. Dufouil C., Alperovitch A., Ducros V., and Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 53 (2003) 214-221
33. Lipton S.A., Kim W., Choi Y.B., Kumar S., D'Emilia D.M., Rayudu P.V., et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 94 (1997) 5923-5928
34. Splaver A., Lamas G.A., and Hennekens C.H. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 148 (2004) 34-40
35. Cesari M., Rossi G.P., Sticchi D., and Pessina A.C. Is homocysteine important as a risk factor for coronary heart disease?. Nutr Metab Cardiovasc Dis 15 (2005) 140-147